EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy

Dan Huang, Xiaoke Chen, Peng Zhuang

Journal of Hepatocellular Carcinoma · 2026-11 · Volume 13 · 1-14

DOI: 10.2147/jhc.s655212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-11. Verfasst von Dan Huang und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Huang, D., Chen, X., & Zhuang, P. (2026). Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy. Journal of Hepatocellular Carcinoma, Volume 13, 1-14. https://doi.org/10.2147/jhc.s655212

Vancouver

Huang D, Chen X, Zhuang P. Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-14. doi:10.2147/jhc.s655212

BibTeX
@article{Huang2026,
  author = {Huang, Dan and Chen, Xiaoke and Zhuang, Peng},
  title = {Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--14},
  doi = {10.2147/jhc.s655212}
}
Kostenlos starten →